Results 191 to 200 of about 74,228 (295)

When and for Whom Does Intensive Care Unit Admission Change the Prognosis in Oncology?-A Scoping Review. [PDF]

Cancers (Basel)
Codru IR, Vecerzan L.
europepmc   +1 more source

The myth of the metabolic baseline: sleep–wake cycles undermine a foundational assumption in organismal biology

Biological Reviews, Volume 101, Issue 3, Page 1491-1510, June 2026.
ABSTRACT Basal and standard metabolic rate (BMR and SMR) are cornerstones of physiological ecology and are assumed to be relatively fixed intrinsic properties of organisms that represent the minimum energy required to sustain life. However, this assumption is conceptually flawed. Many core maintenance processes underlying SMR are temporally partitioned
Helena Norman, Daphne Cortese, Amelia Munson, Jan Lindström, Shaun S. Killen   +4 more
wiley   +1 more source

Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's Disease. [PDF]

Mov Disord
Koch MW, Kalia LV, Sarna J, Aquino C, Wile D, Mestre TA, Schlossmacher MG, D'Haeseleer M, Mostert J, Strijbis EMM, Uitdehaag B, McPherson T, Cutter G.   +12 more
europepmc   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

International Journal of Cancer, Volume 158, Issue 11, Page 2983-2994, 1 June 2026.
What's new? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita, Amalia S. Magaret, David R. Doody, Jeffrey T. Schouten, Constance Mao, Warner K. Huh, Verena S. Grieco, Matthew A. Seymour, Dana Varon, Kelly H. Shrader, Long Fu Xi, Denise A. Galloway, Anna Wald, Margaret M. Madeleine   +13 more
wiley   +1 more source

Perception of futile care and the reasons behind providing it for the patients at end-of-life stages from the care providers' perspective. [PDF]

Philos Ethics Humanit Med
Ramazani R, Beiranvand S, Daei S, Kord Z, Ashrafizadeh H.   +4 more
europepmc   +1 more source

Nonbeneficial (“Futile”) Emergency Medical Interventions [PDF]

Annals of Emergency Medicine, 2017
openaire   +2 more sources

Disentangling Climate Worry and Psychological Distress: Data From the UK Household Longitudinal Study

International Journal of Psychology, Volume 61, Issue 3, June 2026.
ABSTRACT Anxiety and worry about climate change have been associated with poorer mental health. We examined whether different climate beliefs, the cognitive component of climate anxiety, were associated with symptoms of psychological distress. We also tested whether political efficacy moderated the potential associations between climate beliefs and ...
Vilja Helminen, Markus Jokela, Marko Elovainio   +2 more
wiley   +1 more source

Effect of melatonin versus placebo for the prevention of delirium among medically hospitalised older patients: a double-blinded randomised controlled trial (project RESTORE). [PDF]

BMJ Open
Al Alawi AM, Al Busaidi S, Al Rasbi SK, Al Farsi RS, Al Zeedy K, Al Huraizi AR, Al-Maqbali JS.   +6 more
europepmc   +1 more source

Surgery in space: The ultimate frontier

Experimental Physiology, EarlyView.
Mohamad Bashir, Ali Murtada, Matti Jubouri, Adam Bashir, Ian Williams, Damian Bailey   +5 more
wiley   +1 more source

Trastuzumab Deruxtecan for HER2‐Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia

Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 3, Page 381-391, June 2026.
ABSTRACT Trastuzumab deruxtecan (T‐DXd) is a third‐generation, HER2‐targeting antibody‐drug conjugate that has been shown to significantly prolong overall survival, compared with standard chemotherapy, when used to treat patients who have “HER2‐low” (HER2 immunohistochemistry [IHC] score 1+; or HER2 IHC 2+ plus in situ hybridization‐negative ...
Andrew Redfern, Elgene Lim, Sunil Lakhani, Nirmala Pathmanathan, Sudarsha Selva‐Nayagam, Nicole McCarthy, Belinda Yeo, Benjamin Dessauvagie, Gelareh Farshid   +8 more
wiley   +1 more source